This page is dedicated to the design of PFAway. You will find explanations and documentation about how we conceptualized our beads embedding the two bacterial strains for PFAS removal in water, from the molecular level to the process level.
How to degrade long-chain PFAS ?
Labrys portucalensis: a newly described PFAS degrading strain
We started the conceptualization of PFAway by getting to know the state-of-the-art of microbial/enzymatic PFAS degradation from the literature and previous iGEM projects. It was clear that no PFAS catabolism or efficient enzymatic degradation had been described yet.
In fact, enzymes were often identified as active on mono/difluorinated substrates (Wackett and Robinson, 2024), but long-chain PFAS, such as PFOS and PFOA harboring 17 and 15 fluorine atoms, respectively, are too complex substrates for these enzymes. Nonetheless, several articles reported microbial PFAS degradation (Smorada et al., 2024). We identified several strains that had the potential for efficient PFAS degradation, as described in Table 1.
Table 1: Comparison of PFAS degradation by different bacterial strains
| Strain name | Degraded PFAS | Degradation time | Percentage of degradation | Degradation products | Initial PFAS concentration | Culture conditions | Source |
|---|---|---|---|---|---|---|---|
| Pseudomonas parafulva YAB-1 mutant F3-52 | PFOA | Not specified | 58.6% | No analysis of degradation products or fluoride ions | 1200 mg/L | Aerobic, PFOA as sole carbon source | Yi et al., 2019 |
| Pseudomonas aeruginosa HJ4 | PFOS | 48 hours | 67% | Degradation products identified at a non-significant level, no fluoride ions detected | 1400 to 1800 µg/L | Aerobic, 0.1% (v/v) of glucose added in the medium | Kwon et al., 2014 |
| Pseudomonas plecoglossicida DD4 | PFOA | 96 hours | Complete removal | 132 mg/L of fluoride ions, PFHpA | PFOA: 1000 mg/L | Aerobic, PFOA as sole carbon source | Chetverikov and Sharipov, 2022 |
| Pseudomonas plecoglossicida 2.4-D | PFOS | 6 days | 75% | Fluoride ions | PFOS: 1 g/L | Aerobic, PFOS as sole carbon source | Chetverikov et al., 2017 |
| Labrys portucalensis F11 | PFOS | 194 days | 96% | Clearly identified degradation products, defluorination detected | PFOS: 10 mg/L | Aerobic, PFOS as sole carbon source | Wijayahena et al., 2025 |
In the majority of bacterial strains investigated, PFAS degradation is fast and efficient. However, products of degradation have not been clearly identified, and when detected, they primarily correspond to fluoride ions and long-chain intermediates (like PFHpA for Pseudomonas plecoglossicida 2.4-D). This lack of knowledge limits the interest of such strains as the fate of PFAS remains unresolved, which is not suitable for clean water release.
In contrast, the products of degradation of PFOS by Labrys portucalensis have been characterized, and the authors who identified the strain proposed a degradation pathway resulting in PRPrA (clearly identified) and TFA (suspected) (see supplementary Figure S1). The extent of chain shortening observed in this organism is particularly significant, as it opens the possibility of coupling its metabolism with complementary systems capable of defluorinating the resulting short-chain PFAS.
In addition, L. portucalensis was grown in conditions that can easily be scalable (aerobic, with only PFOS as carbon source, in M9 minimal medium). Despite a long degradation time (Table 1), L. portucalensis seems to be the best strain to consider for long-chain PFAS degradation in contaminated water.
We therefore found the starting point of our project: L. portucalensis, a bacterial strain capable of degrading a long-chain PFAS into short-chain PFAS, as shown in Figure 1.
Characterization of L. portucalensis
1- PFOS degradation
We designed an assay to measure the PFOS degradation capacity of L. portucalensis. We used smaller volumes than in Wijayahena et al, 2025 and monitored PFOS degradation over time using LC-MS/MS (measurement performed by the ENVT, Argoul et al., 2025). We attempted to reduce the degradation time of PFOS by starting at two different cell densities (OD600): 0.1 (as in Wijayahena et al, 2025) and 1.
For technical details on the PFOS degradation tests and on safety when working with PFOS, please go to the Protocols page and to the Safety page.
2- Strain characterization
The growth rate of L. portucalensis on glucose was evaluated in M9 minimal media. We also assessed the toxicity of TFA, PFPrA and fluoride ions (using NaF) by monitoring growth curves in the presence of these compounds. The experimental data were used to feed our mathematical model (see our Model page), while providing new insights on the properties of the strain.
For technical details on the toxicity assays, please go to the Protocols page.
We then had to find a way of defluorinating the obtained short-chain PFAS (Figure 1).
How to defluorinate short-chain PFAS ?
Extending PFAS degradation through an evolved dehalogenase
As mentioned previously, enzymatic degradation of fluorinated compounds has not been proven yet for long-chain PFAS. Nonetheless, enzymatic activity has been reported on monofluorinated and difluorinated compounds (Wackett and Robinson, 2024; Dodge et al., 2024; Farajollahi et al., 2024; iGEM USAFA 2020 and 2021 teams).
In fact, the work of iGEM teams USAFA 2019, 2020 and 2021 contributed to identifying a set of five dehalogenase enzymes originating from Delftia acidovorans D4B (formerly Moraxella sp. B): DeHa1 to 5 (Harris et al., 2022). DeHa2 (E.C. 3.8.1.3, Genbank: D90423.1, Uniprot: Q01399) has been characterized on several monofluorinated and difluorinated substrates. Because of this broad activity, DeHa2 was recombinantly expressed in a Pseudomonas putida strain for in vivo degradation of monofluorinated compounds (Dodge et al., 2024), which particularly drew our attention. An overview of DeHa2 activity on different fluorinated compounds is presented in the supplementary Table S1.
In addition, DeHa enzymes have been used by iGEM Padua 2024 for in silico molecular docking, showing that DeHa2 gave the highest docking score with PFOA out of the five D. acidovorans DeHas. Team SDU Denmark 2023 also tried improving the activity of these dehalogenases on PFOA by site-directed mutagenesis, and DeHa2/5 were suggested to have the highest activity improvement.
All these data suggest that DeHa2 is able to defluorinate monofluorinated compounds, and is a good candidate for activity improvement on polyfluorinated molecules such as the targeted PFAS.
To recombinantly express the improved DeHa2, we chose Pseudomonas putida KT2440 as it can easily be engineered and as a close strain has already been used for dehalogenase expression for in vivo degradation of monofluorinated compounds (Dodge et al., 2024).
The complete degradation scheme relying on the two bacterial strains L. portucalensis F11 and P. putida KT2440 is represented in Figure 3.
The need of using DeHa2 with improved activity on short-chain PFAS was also emphasized by our Model outcomes: the reaction parameters for optimal activity of the enzyme on TFA were estimated to be Km = 13.8 mM and Vmax = 0.02 mmol/h (see our Model page - Optimizing dehalogenase). To this end, we decided to evolve DeHa2 using directed evolution.
How to improve the activity of DeHa2 on short-chain PFAS ?
Directed evolution for improving DeHa2
Directed (or laboratory) evolution aims at accelerating natural evolutionary processes of proteins towards a user-defined goal. Mutagenesis techniques are employed to generate libraries of genes, which are then screened in order to select the most valuable variants. Several mutagenesis/screening rounds are performed, enabling to direct the evolution toward the desired protein activity.
In our case, the activity of DeHa2 on short-chain PFAS needs to be improved. We decided to apply directed evolution methods to generate DeHa2 variants and select for the ones with the highest activity on short-chain PFAS, starting with TFA and PFPrA as degradation products of PFOS. We decided to apply orthogonal replication (ORep) for generating variants of the DeHa2 gene (dehH2) coupled to a fluorescence-based droplet microfluidic method to select the best-performing variants. The whole directed evolution process of DeHa2 is represented in Figure 3.
A) Orthogonal replication: 1) The synthetic replication operon containing the four ORep genes is expressed in E. coli DH10B. 2) ORep proteins allow for the specific and mutagenic replication of the linear replicon containing the target dehH2 gene. 3) A library of DeHa2 variants is expressed.
B) Microfluidic cell sorting: 1) ORep E. coli cells expressing DeHa2 variants are mixed with the fluoride-sensitive FluorMango RNA aptamer. 2) Microdroplets containing a single ORep cell and a short-chain PFAS substrate (here TFA) are generated. Cells expressing efficient DeHa2 variants releasing enough fluoride ions activate FluorMango and generate fluorescence in the droplet. 3) Droplets are sorted based on fluorescence level, isolating cells expressing a highly efficient DeHa2 phenotype.
This two-step process is repeated until the desired DeHa2 activity on TFA is reached.
Orthogonal replication (ORep)
This section focuses on explaining why we chose ORep for improving the activity of DeHa2 on short-chain PFAS, and how we designed the strain creation. For an in-detail description of this technique, please refer to Figure 3A.
We initially thought about classical methods for genetic diversification of DeHa2. Supplementary table S2 summarizes the properties of the ones we considered.
We first considered in vitro methods such as epPCR and epRCA. These are highly labor-intensive as they require cloning, expression, and assay of each enzymatic variant. This is why we shifted our focus to in vivo approaches, where continuous improvement of strains is possible since the variants are expressed directly by the host. In this context, we identified a recent study by Tian et al. (2024) describing orthogonal replication (ORep).
ORep is an in vivo hypermutagenesis system that uses intracellular resources to efficiently generate a library of user-defined gene variants without mutating the native genome nor interfering with the host replication machinery. Initially developed in the yeast <Saccharomyces Cerevisiae (Ravikumar et al., 2014) and later in Bacillus thuringiensis (Tian et al., 2023), ORep has recently been implemented in E. coli (Tian et al., 2024).
This technique has several advantages:
• High variant generation rate
• Fast screening without isolating or purifying the gene library
• No risk of deleterious chromosomal mutations
Establishing orthogonal replication in E. coli is a challenging task. We contacted the authors of the original paper to share with us some materials and tips but did not get an answer. Mindful of the broad potential of an orthogonal replication system, we nonetheless decided to implement it fully on our own and to facilitate its wide adoption by future iGEM teams by making all materials and protocols fully available.
We therefore have designed a kit for future users, to facilitate the cloning of their gene of interest in the linear replicon, as part of a directed evolution method. For more details, see our Contribution page.
Design of the ORep system
1- Creation of the replication operon
In Tian et al., 2024, E. coli was engineered to express a synthetic operon composed of four genes involved in the replication of phage PRD1 (Figure 5).
Figure 5: Structure of the synthetic replication operon under the control of IPTG inducible Ptac promoter. Pass the mouse or click on the different components to see their characteristics. |
|
TP
DNAP
SSB
DSB
|
|
Terminal protein gene: expresses the terminal protein that binds to ITR sequences, therefore functioning as origins for replication for PRD1 DNAP.
PRD1 DNA polymerase gene: encodes a DNA polymerase derived from phage PRD1, for which terminal protein (TP) bound to inverted terminal repeats (ITR) naturally serve as replication origins in the phage genome.This DNAP was mutated by the authors to make it error-prone.
Single-stranded DNA-binding protein gene: early-expressed gene in phage PRD1, hypothesized to be necessary for PRD1 replication.
Double-stranded DNA-binding protein gene: early-expressed gene in phage PRD1, hypothesized to be necessary to build to replication.
|
We assembled this operon from three DNA fragments (gBlocks) following the cloning strategy illustrated in Figure 6.
With the intention to increase the mutation rate of our target gene, we chose to use a DNAP bearing two mutations which, when introduced individually, increase the polymerase mutagenic capacity. The mutation rates of the single-mutant DNAPs are provided in Table 2. The mutation rate of the double-mutant DNAP was not characterized by Tian et al.
Table 2: Mutation rates on the linear replicon of the DNAP variants. Rates are expressed in substitutions per base pair per generation (Tian et al., 2024)
| Mutation | Mutation rate of mutated DNAP (s.p.b.) |
|---|---|
| N71D | 9.13 x 10-7 |
| Y127A | 5.61 x 10-7 |
The next step was the implementation of the operon in E. coli DH10B for expression.
2- Implementation of the replication operon in E. coli DH10B
The two options in hand were to insert the operon in the E. coli chromosome or to introduce it in a single-copy plasmid with which E. coli will be transformed. Discussing with Denis Jallet, we learned that chromosomic integration in the SS9 site of E. coli DH10B was commonly performed in his lab. We therefore decided to attempt chromosomic insertion of the replication operon.
![]() |
![]() |
| Denis Jallet is Researcher at the Toulouse Biotechnology Institute (TBI), specialized in Microbiology. He shared with us his protocols and materials for chromosomic insertion of genes in the E. coli genome, using the non-essential chromosomic site SS9. |
Following Denis’ advice, we designed plasmids to implement the chromosomal insertion in the SS9 site, as illustrated in Figure 7.
Unfortunately the chromosomal insertion approach did not lead to the expected results and we set out to clone the operon in a single-copy plasmid. Our cloning strategy for implementing the replication operon on a single-copy plasmid is represented in Figure 8.
You can find out about the related DBTL cycles concerning these strategies in the Engineering page.
3- Creation of the linear replicon
Tian and coworkers proved that expression of the orthogonal replication operon led to the mutagenic replication of a linear replicon consisting of a double stranded linear DNA flanked with ITRs containing a user-defined gene (here, dehH2) and a kanamycine resistance gene (KanR). Figure 9 illustrates our cloning strategy for the linear replicon.
In this way, the ORep system is established: the synthetic replication operon enables the mutagenic replication of the linear replicon containing the DeHa2 gene (dehH2) and generates a library of variants. Our next task was to design a screening technique for the selection of the best variants.
Fluorescence-activated droplet sorting for the selection of DeHa2 variants
The activity of efficient DeHa2 variants generated by ORep will lead to the release of fluoride ions during short-chain PFAS degradation. We therefore chose to develop a screening technique based on the quantitative detection of the released fluoride ions using a fluorescence-based biosensor.
We first opted for the fluoride-sensitive riboswitch crcB (Baker et al., 2012), originally characterized from the Bacillus cereus crcB gene, which was shown to activate the expression of a reporter gene in response to fluoride. Inspired by the work of team SDU Denmark 2023, we aimed to adapt this strategy to control sfGFP expression, unsuccessfully. Therefore, we set out to implement another fluoride biosensor, named FluorMango. The engineering cycles for these strategies are further discussed in the Engineering page.
FluorMango is an RNA aptamer allowing for the direct quantification of fluoride by fluorescence (Husser et al., 2023). The structure and principle of this aptamer is presented in Figure 10.
When combined with the directed evolution cycle of DeHa2 (Figure 3), FluorMango serves as a reporter of the activity of the different DeHa2 variants expressed in E. coli ORep cells: the more efficient the degradation of short-chain PFAS, the higher the concentration of fluoride ions released in the external medium, and the higher the fluorescence intensity of FluorMango.
Importantly, because FluorMango cannot permeate the cell membrane, the ORep cells are individually encapsulated into microfluidic droplets to create a linkage between the gene variants and the phenotypic output, here the fluorescence intensity of FluorMango. Microfluidic droplet sorting is then employed to selectively isolate droplets exhibiting the highest fluorescence, thereby enriching for the most active variants. These enriched populations are subjected to iterative rounds of screening to progressively enhance catalytic performance. An overview of the directed evolution workflow is depicted in Figure 3B.
Proof of concept of the FluorMango screening method
1- Production of FluorMango
We chose to produce the FluorMango aptamer by annealing DNA primers followed by transcription with T7 RNA polymerase (Figure 11).
2- Assessing FluorMango’s sensitivity
According to Husser et al., 2023, the FluorMango aptamer shows a linear response to fluoride concentrations within a range of 150 µM to 1 mM, with a limit of detection of 68 µM and a limit of quantification of 90 µM. Therefore, we tested the response of the FluorMango aptamer in microplates across a fluoride concentration range of 0.1 mM to 3 mM, using NaF to generate the desired F- concentrations.
To find out about the results of FluorMango tests in microplates, please go to our Best Measurement page.
3- Assessing FluorMango’s specificity
According to Husser et al., 2023, the FluorMango aptamer displays a remarkable specificity for fluoride as no fluorescence was observed in the presence of other halide ions. To ensure that the fluorescence detected is only due to the presence of fluoride ions under our conditions, we performed other negative controls with the aptamer in microplates described in Table 3.
Table 3: Negative controls performed with the FluorMango aptamer in microplate conditions..
| Molecule | Purpose |
|---|---|
| NaCl | Assuring that Na+ ions do not affect the sensitivity test |
| TFA | Assuring that DeHa2 substrate does not activate the FluorMango aptamer |
| Fluo-Oil 135 | Assuring that the fluorinated oil used in microfluidic droplets does not induce fluorescence |
For more information about the results of FluorMango tests in microplates, please go to our Best Measurement page.
4- Monitoring Defluorination Activity Using FluorMango
In contrast to Husser et al., 2023, we used 2-fluoropropionic acid instead of fluoroacetate as a monofluorinated substrate of DeHa2, due to its lower toxicity. According to Dodge et al., 2024, the Delftia acidovorans defluorinase DeHa2 efficiently degrades 2-fluoropropionic acid, with a specific activity of 1.7 ± 0.2 µmol·min-1·mg-1 as shown in Table S1. We therefore measured the real-time production of fluoride ions from 2-fluoropropionic acid by DeHa2 expressed in E. coli DH5α and induced with IPTG.
To find out about the results of FluorMango assays in microplates, please go to our Best Measurement page.
5- Enrichment of Fluoride-containing droplets with microfluidics
We designed a mock library experiment, whereby samples containing either FluorMango without NaF (negative control) or FluorMango with NaF were incubated for 1 hour. Then, droplets were generated from each sample, mixed to produce a population containing 20% of NaF-loaded droplets, and subjected to microfluidic sorting. Widefield fluorescence microscopy was used to observe droplet stability and sorting efficiency.
To learn more about the results of microfluidics assays, please visit our Best Measurement page. All protocols are accessible on our Protocols page.
Upon discovery of an active dehalogenase for the degradation of short-chain PFAS, a large amount of fluoride ions, beyond the toxicity threshold, will be released within the bacterium, here Pseudomonas putida. Consequently, the bacterial resistance to fluoride must be improved.
How to deal with generated fluoride ions ?
Improving P. putida’s response to fluoride stress
Pseudomonas putida KT2440 expressing the evolved DeHa2 will be exposed to large amounts of fluoride ions. We first thought that the natural resistance of P. putida could support fluoride resistance, but our modeling approach proved the contrary. Therefore, its tolerance to fluoride stress must be enhanced. You can find out about this engineering cycle on the Engineering page.
Defluorination of monofluorinated compounds by a recombinant DeHa in P. putida releases up to 50 mM of F- in the extracellular medium (Dodge et al., 2024). The minimal inhibitory concentration (MIC) of fluoride ions for P. putida KT2440 in M9 minimal medium being 75 mM (Calero et al., 2022), we understand the importance of enhancing the fluoride stress resistance capacity of our chassis, especially if it comes to degrade multifluorinated compounds with the improved DeHa2.
We chose P. putida as a chassis for the DeHa2 expression because it is a widely studied genus for broad stress tolerance tests, harboring a particularly efficient redox metabolism (Martínez-García and de Lorenzo, 2024). Moreover, genes expressed in response to fluoride stress were identified for strain KT2440. fluC, a gene coding for a fluoride specific transporter, was identified as the main feature expressed during fluoride exposure (Calero et al., 2022).
FluC proteins are dimeric transmembrane transporters, highly specific for F- anions and playing a major role in fluoride stress resistance (Stockbridge and Wackett, 2024). Their efflux rate stands at 106 ions/s (Khusnutdinova et al., 2023), and the deletion of fluC in P. putida results in a highly F--sensitive strain with a MIC of 0.5 mM of F- in M9 minimal medium (~100 fold lower than for the WT KT2440 strain) (Calero et al., 2022).
Since the literature indicated a strong link between FluC’s expression and P. putida’s sensitivity to F- ions, and as fluC seemed to be under fluoride sensitive epigenetic control, we decided to constitutively overexpress this transporter as an attempt to enhance the resistance of P. putida to F- ions.
This enabled us to achieve an end-to-end degradation process of PFAS, as represented in Figure 12:
Overexpressing FluC in P. putida KT2440
1- Creation of pSEVA438-fluC
We constructed a plasmid named pSEVA438-fluC that contained the fluC gene directly amplified from the genome of P. putida KT2440, under the control of a m-toluic acid inducible promoter (Pm). The cloning strategy of pSEVA438-fluC is depicted in Figure 13.
2- Testing of P. putida WT against P. putida pSEVA438-fluC
P. putida KT2440 was then transformed with pSEVA438-fluC. Overexpression of fluC was induced in the modified strain without any fluoride sensitive upstream regulation mechanism.
MIC assays and growth curves analysis were conducted using varying concentrations of NaF in microplates for both KT2440 WT and KT2440-pSEVA438-fluC strains. We also conducted toxicity assays for TFA and PFPrA on KT2440-pSEVA438-fluC for further characterization of the strain.
For more details about the protocols of toxicity assays, please visit our Protocols page.
How to implement PFAway at the industrial scale ?
Entrepreneurship design
Entrepreneurship involves translating our PFAS remediation solution into real-world applications by integrating it into water treatment systems. We therefore needed to think of an industrial approach to effectively combine our two strains L. portucalensis and P. putida (Figure 12).
Our initial idea was to grow the two strains as a co-culture in a bioreactor for the degradation of PFAS contained in contaminated water. However, this approach presented several difficulties:
1- Even though the strains can be cultivated in the same medium and growth conditions, they show very different growth rates, respectively 0.24 h-1 and 0.55 h-1 for L. portucalensis (estimated based on Wijayahena et al, 2025) and P. putida (estimated in the lab and confirmed by Calero et al., 2022). This means that P. putida would overgrow L. portucalensis, which is prohibitive for the sequential degradation of long- and short-chain PFAS.
2- Direct co-cultivation in the treated water would complicate downstream separation and risk GMO release, which is strictly legislated in France.
To overcome these challenges, we contacted companies specializing in bioremediation and strain industrialization. Our first contact was with YpHen: a French company developing bioremediation solutions for soil decontamination.


We expressed our concerns to Carmen Mirabelli, researcher at YpHen. After several discussions, she introduced us to a method YpHen is developing to treat pollution in industrial contexts: immobilizing bacteria in biodegradable beads.
Encapsulating the two strains individually in beads would solve both problems linked with culture in a bioreactor. It allows the bacteria to work efficiently without the competition issues inherent to co-culture, and, depending on their formulation, the beads can prevent the release of bacteria into water, addressing GMO-related concerns as well. Based on these considerations, we decided to collaborate with Carmen and Yphen to produce prototype beads.
Assessing the efficiency of beads for encapsulation of our bacterial strains
With the help of Carmen, we designed experiments to test the first prototypes, focusing on PFAS adsorption, bacterial viability over time within the beads, and potential bacterial release. For more details about prototype beads testing, please visit our Protocols page.
1- Production of beads
This part of the work was carried out in Grenoble at Yphen’s facilities, where the team has the most expertise in bead production. During the process, we tested several bead formulations, varying the activated carbon content at 10% and 20% to evaluate its effect on PFAS adsorption. Beads without activated carbon were also produced to determine if any other components of the bead might contribute to PFAS adsorption.
2- PFAS adsorption on beads
Following bead production, we conducted experiments to test the adsorption of PFAS (here PFOA) on beads containing 10% and 20% activated carbon, as well as on beads without activated carbon. These experiments are essential to inform the optimization of bead formulations for the next stages of development.
3- Strain viability in the beads
For the beads to effectively degrade PFAS, it is crucial that living bacteria remain active throughout the treatment period, which can be estimated using our model (see our Model page). We performed viability tests over 15 days to confirm that the bacteria remain active over this period. If bacteria survive for longer durations, the beads could be reused, reducing both the ecological footprint of the solution and its operational costs.
4- Bacterial release in water
Biosafety was a major focus, as highlighted by our human practice survey (see HP page). It was essential to ensure that the bacteria, especially the genetically modified P. putida, could not be released from the beads into the treated water.


Raphaëlle Aubert is a French Data journalist at Le Monde. While describing our project, her first question was if engineered bacteria would be released in water after treatment. This highlighted the concern about public apprehension for GMO containment.
To evaluate this, we conducted experiments measuring bacteria release in demineralized water. Future experiments will test beads under conditions closer to real-world water systems. Measures to minimize GMO release have already been planned, mainly through improvements in bead formulation and production processes.
Entrepreneurship design
Entrepreneurship involves translating our PFAS remediation solution into real-world applications by integrating it into water treatment systems. We therefore needed to think of an industrial approach to effectively combine our two strains L. portucalensis and P. putida (Figure 12).
Our initial idea was to grow the two strains as a co-culture in a bioreactor for the degradation of PFAS contained in contaminated water. However, this approach presented several difficulties:
1- Even though the strains can be cultivated in the same medium and growth conditions, they show very different growth rates, respectively 0.24 h-1 and 0.55 h-1 for L. portucalensis (estimated based on Wijayahena et al, 2025) and P. putida (estimated in the lab and confirmed by Calero et al., 2022). This means that P. putida would overgrow L. portucalensis, which is prohibitive for the sequential degradation of long- and short-chain PFAS.
2- Direct co-cultivation in the treated water would complicate downstream separation and risk GMO release, which is strictly legislated in France.
To overcome these challenges, we contacted companies specializing in bioremediation and strain industrialization. Our first contact was with YpHen: a French company developing bioremediation solutions for soil decontamination.
![]() |
![]() |
| We expressed our concerns to Carmen Mirabelli, researcher at YpHen. After several discussions, she introduced us to a method YpHen is developing to treat pollution in industrial contexts: immobilizing bacteria in biodegradable beads. |
Encapsulating the two strains individually in beads would solve both problems linked with culture in a bioreactor. It allows the bacteria to work efficiently without the competition issues inherent to co-culture, and, depending on their formulation, the beads can prevent the release of bacteria into water, addressing GMO-related concerns as well. Based on these considerations, we decided to collaborate with Carmen and Yphen to produce prototype beads.
Assessing the efficiency of beads for encapsulation of our bacterial strains
With the help of Carmen, we designed experiments to test the first prototypes, focusing on PFAS adsorption, bacterial viability over time within the beads, and potential bacterial release. For more details about prototype beads testing, please visit our Protocols page.
1- Production of beads
This part of the work was carried out in Grenoble at Yphen’s facilities, where the team has the most expertise in bead production. During the process, we tested several bead formulations, varying the activated carbon content at 10% and 20% to evaluate its effect on PFAS adsorption. Beads without activated carbon were also produced to determine if any other components of the bead might contribute to PFAS adsorption.
2- PFAS adsorption on beads
Following bead production, we conducted experiments to test the adsorption of PFAS (here PFOA) on beads containing 10% and 20% activated carbon, as well as on beads without activated carbon. These experiments are essential to inform the optimization of bead formulations for the next stages of development.
3- Strain viability in the beads
For the beads to effectively degrade PFAS, it is crucial that living bacteria remain active throughout the treatment period, which can be estimated using our model (see our Model page). We performed viability tests over 15 days to confirm that the bacteria remain active over this period. If bacteria survive for longer durations, the beads could be reused, reducing both the ecological footprint of the solution and its operational costs.
4- Bacterial release in water
Biosafety was a major focus, as highlighted by our human practice survey (see HP page). It was essential to ensure that the bacteria, especially the genetically modified P. putida, could not be released from the beads into the treated water.
![]() |
![]() |
| Raphaëlle Aubert is a French Data journalist at Le Monde. While describing our project, her first question was if engineered bacteria would be released in water after treatment. This highlighted the concern about public apprehension for GMO containment. |
To evaluate this, we conducted experiments measuring bacteria release in demineralized water. Future experiments will test beads under conditions closer to real-world water systems. Measures to minimize GMO release have already been planned, mainly through improvements in bead formulation and production processes.
| Next, find out about our engineering cycles here: |
|
|
